These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 2735664)

  • 1. Influence of platelet factor 4 on the neutralization of heparin by protamine.
    Shanberge JN; Quattrociocchi-Longe TM
    Ann N Y Acad Sci; 1989; 556():354-65. PubMed ID: 2735664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interrelationship of protamine and platelet factor 4 in the neutralization of heparin.
    Shanberge JN; Quattrociocchi-Longe TM; Martens MH
    Thromb Res; 1987 Apr; 46(1):89-100. PubMed ID: 3590116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin neutralization by recombinant platelet factor 4 and protamine.
    Levy JH; Cormack JG; Morales A
    Anesth Analg; 1995 Jul; 81(1):35-7. PubMed ID: 7598278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet factor four and protamine sulfate neutralization of heparin fractionated according to anionic charge density.
    Poon MC; Hurst RE; Rives MS
    Thromb Haemost; 1982 Apr; 47(2):162-5. PubMed ID: 7101237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralization of DHG, a new depolymerized holothurian glycosaminoglycan, by protamine sulfate and platelet factor 4.
    Sasaki E; Minamiguchi K; Kitazato KT; Nagase H; Kitazato K
    Haemostasis; 1997; 27(4):174-83. PubMed ID: 9483172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of protamine sulfate on antithrombin III activity.
    Matsuo T; Shanberge JN; Matsuo O
    Clin Chim Acta; 1983 Jul; 131(3):233-8. PubMed ID: 6883717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human platelet factor 4 and protamine sulphate interaction with glycosaminoglycans in the rabbit.
    Cella G; Myers CJ; Prosdocimi M; Sasahara AA
    Eur J Clin Invest; 1987 Dec; 17(6):548-54. PubMed ID: 3123254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of lysed platelets on neutralization of heparin in vitro with protamine as measured by the activated coagulation time (ACT).
    Bode AP; Castellani WJ; Hodges ED; Yelverton S
    Thromb Haemost; 1991 Aug; 66(2):213-7. PubMed ID: 1771614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of platelet factor 4 (PF4) on assays of plasma heparin.
    Levine SP; Sorenson RR; Harris MA; Knieriem LK
    Br J Haematol; 1984 Aug; 57(4):585-96. PubMed ID: 6743573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet factor 4 efficiently reverses heparin anticoagulation in the rat without adverse effects of heparin-protamine complexes.
    Cook JJ; Niewiarowski S; Yan Z; Schaffer L; Lu W; Stewart GJ; Mosser DM; Myers JA; Maione TE
    Circulation; 1992 Mar; 85(3):1102-9. PubMed ID: 1537108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dextran sulfate included in factor Xa assay reagent overestimates heparin activity in patients after heparin reversal by protamine.
    Mouton C; Calderon J; Janvier G; Vergnes MC
    Thromb Res; 2003; 111(4-5):273-9. PubMed ID: 14693175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transgenic mice studies demonstrate a role for platelet factor 4 in thrombosis: dissociation between anticoagulant and antithrombotic effect of heparin.
    Eslin DE; Zhang C; Samuels KJ; Rauova L; Zhai L; Niewiarowski S; Cines DB; Poncz M; Kowalska MA
    Blood; 2004 Nov; 104(10):3173-80. PubMed ID: 14764524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of heparin anticoagulation by recombinant platelet factor 4 and protamine sulfate in baboons during cardiopulmonary bypass.
    Bernabei A; Gikakis N; Maione TE; Kowalska MA; Yan Z; Niewiarowski S; Edmunds LH
    J Thorac Cardiovasc Surg; 1995 Apr; 109(4):765-71. PubMed ID: 7715225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of protamine sulfate with thrombin.
    Cobel-Geard RJ; Hassouna HI
    Am J Hematol; 1983 May; 14(3):227-33. PubMed ID: 6846326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin-protamine complexes in the production of heparin rebound and other complications of extracorporeal bypass procedures.
    Shanberge JN; Murato M; Quattrociocchi-Longe T; van Neste L
    Am J Clin Pathol; 1987 Feb; 87(2):210-7. PubMed ID: 3812352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of low-molecular-weight heparin reversal by platelet factor 4.
    Fiore MM; Mackie IM
    Thromb Res; 2009 May; 124(1):149-55. PubMed ID: 19195682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the neutralizing mechanism of antithrombin activity of heparin by protamine.
    Okajima Y; Kanayama S; Maeda Y; Urano S; Kitani T; Watada M; Nakagawa M; Ijichi H
    Thromb Res; 1981 Oct 1-15; 24(1-2):21-9. PubMed ID: 7330836
    [No Abstract]   [Full Text] [Related]  

  • 18. Disruption of PF4/H multimolecular complex formation with a minimally anticoagulant heparin (ODSH).
    Joglekar MV; Quintana Diez PM; Marcus S; Qi R; Espinasse B; Wiesner MR; Pempe E; Liu J; Monroe DM; Arepally GM
    Thromb Haemost; 2012 Apr; 107(4):717-25. PubMed ID: 22318669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of heparin, protamine and polybrene on the time integral of thrombin generation (endogenous thrombin potential).
    Rotteveel RC; Roozendaal KJ; Weijers RN; Eijsman L
    Haemostasis; 1996; 26(1):1-10. PubMed ID: 8698272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protamine inhibits formation of the covalent factor IXa-anti-thrombin complex.
    Brecher AS; Roland AR
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):591-6. PubMed ID: 18685444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.